The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Latanoprost
latanoprost · LATANOPROST 50 ug/mL · Solution/ Drops · Ophthalmic · Proficient Rx LP
NDC 71205-0154-25 · 1 BOTTLE in 1 CARTON / 2.5 mL in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for latanoprost (other) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Proficient Rx LPUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA201006
- TE code
- AT
- Approval date
- Mar 22, 2011
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of latanoprost (Solution/ Drops)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Incorporated | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Micro Labs Limited | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| NuCare Pharmaceuticals,Inc. | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | LATANOPROST .05 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Viatris Specialty LLC | LATANOPROST 50 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Latanoprost — NDC 71205-0154-25," retrieved September 3, 2026, https://drugdashboards.com/drug/71205015425.
Free to cite with attribution — see how the data is put together.